Some other potential therapeutic targets for treating autoimmune diseases, such as SLE, are the polyamine synthesis (SMS, ODC, AMD1) and recycling (SAT1) enzymes, transglutaminases, peptidyl arginine deiminases (related to NETosis [118]), and EBV genes. Here, SAT1 is linked to systemic lupus erythematosus.